Published in Expert Opin Drug Saf on November 01, 2009
An Update on Drug-induced Liver Injury. J Clin Exp Hepatol (2012) 1.01
Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Rev Gastroenterol Hepatol (2015) 0.92
Hepatotoxicity by Drugs: The Most Common Implicated Agents. Int J Mol Sci (2016) 0.85
A Time to Pause and Reflect: When a Patient with Autoimmune Hepatitis Stops Responding to Corticosteroids. Case Rep Gastrointest Med (2016) 0.75
Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut (2017) 0.75
Drug-induced liver injury: insights from genetic studies. Pharmacogenomics (2009) 1.10
Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. World J Gastroenterol (2007) 1.03
Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol (2011) 0.93
Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection. Clin Ther (2009) 0.87
[Hepatotoxicity induced by new immunosuppressants]. Gastroenterol Hepatol (2009) 0.79
Recurrent hepatotoxicity associated with etanercept and adalimumab but not with infliximab in a patient with rheumatoid arthritis. Rev Esp Enferm Dig (2012) 0.76
Idiosyncratic drug hepatotoxicity: a 2008 update. Expert Rev Clin Pharmacol (2008) 0.76
Chronic hepatitis C, ibuprofen, and liver damage. Am J Gastroenterol (2002) 0.76
[Acute cholestatic hepatitis associated with levofloxacin]. Gastroenterol Hepatol (2011) 0.76
[Acute hepatitis due to bentazepam]. Med Clin (Barc) (2003) 0.75
Hepatotoxicity in 2011--advancing resolutely. Rev Esp Enferm Dig (2011) 0.75